These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7365745)

  • 1. Cyclophosphamide potentiation and aldehyde oxidase inhibition by phosphorylated aldehydes and acetals.
    Cates LA; Jones GS; Good DJ; Tsai HY; Li VS; Caron N; Tu SC; Kimball AP
    J Med Chem; 1980 Mar; 23(3):300-4. PubMed ID: 7365745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of sensitivity to oxazaphosphorines by inhibitors of aldehyde dehydrogenase activity in cultured oxazaphosphorine-resistant L1210 and cross-linking agent-resistant P388 cell lines.
    Sladek NE; Landkamer GJ
    Cancer Res; 1985 Apr; 45(4):1549-55. PubMed ID: 3978623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of aldehyde dehydrogenase inhibitors on the ex vivo sensitivity of human multipotent and committed hematopoietic progenitor cells and malignant blood cells to oxazaphosphorines.
    Kohn FR; Landkamer GJ; Manthey CL; Ramsay NK; Sladek NE
    Cancer Res; 1987 Jun; 47(12):3180-5. PubMed ID: 3034402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of the cytotoxic action of mafosfamide by N-isopropyl-p-formylbenzamide, a metabolite of procarbazine.
    Maki PA; Sladek NE
    Cancer Res; 1991 Aug; 51(16):4170-5. PubMed ID: 1868438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of cytosolic aldehyde dehydrogenase from cyclophosphamide resistant L1210 cells.
    Russo JE; Hilton J
    Cancer Res; 1988 Jun; 48(11):2963-8. PubMed ID: 3365687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deoxyribonucleic acid crosslinking by 4-hydroperoxycyclophosphamide in cyclophosphamide-sensitive and -resistant L1210 cells.
    Hilton J
    Biochem Pharmacol; 1984 Jun; 33(12):1867-72. PubMed ID: 6732847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldehyde dehydrogenase activity as the basis for the relative insensitivity of murine pluripotent hematopoietic stem cells to oxazaphosphorines.
    Kohn FR; Sladek NE
    Biochem Pharmacol; 1985 Oct; 34(19):3465-71. PubMed ID: 2996550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromate reduction by rabbit liver aldehyde oxidase.
    Banks RB; Cooke RT
    Biochem Biophys Res Commun; 1986 May; 137(1):8-14. PubMed ID: 2941018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of some benzothiazoles, benzoxazoles, and quinolines as substrates and inhibitors of rabbit liver aldehyde oxidase.
    Gristwood W; Wilson K
    Xenobiotica; 1988 Aug; 18(8):949-54. PubMed ID: 3188574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the selective action of cyclophosphamide (NSC-26271): Inactivation of the hydroxylated metabolite by tissue-soluble enzymes.
    Cox PJ; Phillips BJ; Thomas P
    Cancer Treat Rep; 1976 Apr; 60(4):321-6. PubMed ID: 179712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinamide adenine dinucleotide phosphate-decanaldehyde adduct as an inhibitor of beef brain NADP-linked aldehyde reductase.
    Towell JF; Erwin VG; Deitrich RA
    J Med Chem; 1979 Aug; 22(8):1011-4. PubMed ID: 40025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of human liver aldehyde dehydrogenases that catalyze the oxidation of aldophosphamide and retinaldehyde.
    Dockham PA; Lee MO; Sladek NE
    Biochem Pharmacol; 1992 Jun; 43(11):2453-69. PubMed ID: 1610409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydralazine: a potent inhibitor of aldehyde oxidase activity in vitro and in vivo.
    Johnson C; Stubley-Beedham C; Stell JG
    Biochem Pharmacol; 1985 Dec; 34(24):4251-6. PubMed ID: 3841000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of aldehyde dehydrogenase inhibitors on enzymes involved in the metabolism of biogenic aldehydes in rat liver and brain.
    Hellström E; Tottmar O
    Biochem Pharmacol; 1982 Dec; 31(23):3899-905. PubMed ID: 7159468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined antitumor effect of cyclophosphamide and bromodeoxyuridine in BDF1 mice bearing L1210 ascites tumors.
    Kagawa Y; Noge I; Higashigawa M; Komada Y
    Biol Pharm Bull; 2008 Jan; 31(1):57-61. PubMed ID: 18175942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro oxidation of famciclovir and 6-deoxypenciclovir by aldehyde oxidase from human, guinea pig, rabbit, and rat liver.
    Rashidi MR; Smith JA; Clarke SE; Beedham C
    Drug Metab Dispos; 1997 Jul; 25(7):805-13. PubMed ID: 9224775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An extremely potent anilinoacridine inhibitor of aldehyde oxidase.
    Gormley PE; Rossitch E; D'Anna ME; Cysyk R
    Biochem Biophys Res Commun; 1983 Oct; 116(2):759-64. PubMed ID: 6689124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adriamycin and cyclophosphamide in combination chemotherapy of L1210 leukemia.
    Avery TL; Roberts D
    Cancer Res; 1977 Mar; 37(3):678-83. PubMed ID: 837368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of the activity of cisplatin and cyclophosphamide by trimidox, a novel ribonucleotide reductase inhibitor, in leukemia-bearing mice.
    Novotny L; Rauko P; Liska J; Elford HL; Szekeres T
    Cancer Lett; 2006 Feb; 233(1):178-84. PubMed ID: 15885888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic characterization of the catalysis of "activated" cyclophosphamide (4-hydroxycyclophosphamide/aldophosphamide) oxidation to carboxyphosphamide by mouse hepatic aldehyde dehydrogenases.
    Manthey CL; Sladek NE
    Biochem Pharmacol; 1988 Jul; 37(14):2781-90. PubMed ID: 3395357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.